MICHELE CERRA: Open Payments
NPI 1962616268 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$51,606 in 105 payments from 8 companies in 2025. Trend: 2023 $110,906 · 2024 $64,530 · 2025 $51,606
Speaker / faculty: $32,483Travel & lodging: $8,363Consulting: $6,899Food & beverage: $3,861
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 37 | $21,368 |
| GENZYME CORPORATION | 26 | $13,486 |
| AstraZeneca Pharmaceuticals LP | 25 | $8,933 |
| Janssen Scientific Affairs, LLC | 7 | $5,767 |
| SOBI, INC | 4 | $1,554 |
| Amgen Inc. | 3 | $316 |
| ABBVIE INC. | 2 | $156 |
| UCB, Inc. | 1 | $27 |
Products named: TREMFYA, KEVZARA, SAPHNELO, OTEZLA, RINVOQ, UPLIZNA, Bimzelx.
Industry payments across NC — which companies pay providers there.
